ENGLEWOOD, Colo., Dec. 2,
2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI),
an innovative medical technology company specializing in the
manufacture and sale of non-invasive medical devices for pain
management, stroke rehabilitation, cardiac monitoring and
neurological diagnostics today announced that Dan Moorhead, Chief Financial Officer of Zynex
will present at the Piper Jaffray 31st Annual Healthcare
Conference on Thursday, December 5,
2019 in New York, NY.
Mr. Moorhead will also meet with members of the investment
community during one-on-one meetings at the conference.
Event:
|
Piper Jaffray
31st Annual Healthcare Conference
|
Date:
|
Thursday, December 5,
2019
|
Presentation
Time:
|
9:10 AM – 9:30 AM
ET
|
Location:
|
Lotte New York
Palace
New York, New York
|
The presentation will be webcast live on
https://event.webcasts.com/starthere.jsp?ei=1274550&tp_key=636640f30d as
well as the Investors section of the Company's website at
http://zynexmed.investorroom.com/presentations-events-and-webcasts.
Interested parties can also access an archived version of the
presentation on the Company's website for approximately 90 days
after the event concludes.
ABOUT ZYNEX
Zynex, founded in 1996, markets and sells
its own design of electrotherapy medical devices used for pain
management and rehabilitation; and the company's proprietary
NeuroMove device designed to help recovery of stroke and spinal
cord injury patients. Zynex is also developing a new blood volume
monitor for use in hospitals and surgery centers. For
additional information, please visit: zynex.com.
Safe Harbor Statement
Certain statements in this
release are "forward-looking" or projections and as such are
subject to numerous risks and uncertainties. The company makes no
express or implied representation or warranty as to the
completeness of this information or, in the case of projections, as
to their attainability or the accuracy and completeness of the
assumptions from which they are derived. Actual results may vary
significantly from the results expressed or implied in such
statements. Factors that could cause actual results to materially
differ from forward-looking statements include, but are not limited
to, the need to obtain FDA clearance and CE marking of new
products, the acceptance of new products as well as existing
products by doctors and hospitals, larger competitors with greater
financial resources, the need to keep pace with technological
changes, our dependence on the reimbursement for our products from
health insurance companies, our dependence on third party
manufacturers to produce our goods on time and to our
specifications, implementation of our sales strategy including a
strong direct sales force and other risks described in our filings
with the Securities and Exchange Commission including the "Risk
Factors" section of our Annual Report on Form 10-K for the year
ended December 31, 2018 as well as Forms 10-Q, 8-K and
8-K/A, press releases and the Company's website.
INVESTOR RELATIONS CONTACT:
Amato and Partners,
LLC
100 Park Avenue, 16th Floor
New York, NY 10017
(212) 430-0360
admin@amatoandpartners.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/zynex-to-present-at-the-piper-jaffray-31st-annual-healthcare-conference-300966433.html
SOURCE Zynex